In other countries
The same active substances on other registers, the same brand first.
- AG-LamotrigineCanada · 150 MG · Tablet · Angita Pharma INC.Same form
- AG-LamotrigineCanada · 25 MG · Tablet · Angita Pharma INC.Same form
- AG-LamotrigineCanada · 100 MG · Tablet · Angita Pharma INC.Same form
- Arvind 100 mg tableteCroatia · tableta · Belupo lijekovi i kozmetika d.d., Ulica Danica 5, KoprivnicaSame form
- Arvind 25 mg tableteCroatia · tableta · Belupo lijekovi i kozmetika d.d., Ulica Danica 5, KoprivnicaSame form
- Arvind 50 mg tableteCroatia · tableta · Belupo lijekovi i kozmetika d.d., Ulica Danica 5, KoprivnicaSame form
- AmalessItaly · Compressa dispersibile · Aurobindo Pharma (Italia) S.R.L.Same form
- LamictalItaly · Compressa dispersibile · Farma 1000 S.R.L.Same form
- LamictalItaly · Compressa dispersibile · BB Farma S.R.L.Same form
- Lambipol 100 mg, kauwtabletten/dispergeerbare tablettenNetherlands · Kauwtablet, Dispergeerbare tablet · GlaxoSmithKline B.V.Same form
- Lambipol 200 mg, kauwtabletten/dispergeerbare tablettenNetherlands · Kauwtablet, Dispergeerbare tablet · GlaxoSmithKline B.V.Same form
- Lambipol 25 mg, kauwtabletten/dispergeerbare tablettenNetherlands · Kauwtablet, Dispergeerbare tablet · GlaxoSmithKline B.V.Same form
- LamictalNew Zealand · Tab dispersible 2 mgSame form
- LamictalNew Zealand · Tab dispersible 5 mgSame form
- LogemNew Zealand · Tab dispersible 25 mgSame form
- Lamal®Serbia · 25mg · tableta · Alkaloid D.O.O. BeogradSame form
- Lamal®Serbia · 25mg · tableta · Alkaloid D.O.O. BeogradSame form
- Lamal®Serbia · 200mg · tableta · Alkaloid D.O.O. BeogradSame form
- LAMIRA 100 mg TABLETSaudi Arabia · SpimacoSame form
- LAMIRA 25 mg TABLETSaudi Arabia · SpimacoSame form
- LAMIRA 50 mg TABLETSaudi Arabia · SpimacoSame form
- Apo-Lamotrigine 100mg TabletSingapore · 100.0 mg · tablet · Pharmaforte Singapore Pte LTDSame form
- Apo-Lamotrigine 25mg TabletSingapore · 25.0 mg · tablet · Pharmaforte Singapore Pte LTDSame form
- LAMICTAL DISPERSIBLE TABLET 5 mgSingapore · 5 mg · tablet · Glaxosmithkline Pte LTDSame form
- Lamictal XRUnited States · 100MG, 200MG, 250MG … · tablet, extended release · Smithkline BeechamSame form
- LamotrigineUnited States · 100MG, 200MG, 250MG … · tablet, extended release · Actavis ElizabethSame form
- LamotrigineUnited States · 100MG, 150MG, 200MG … · tablet · Zydus Pharms USASame form
- ExafobBrazil · Geolab Indústria Farmacêutica S/ASame substance
- ForlutBrazil · Biolab Sanus Farmacêutica LtdaSame substance
- LamezBrazil · Accord Farmacêutica LtdaSame substance
- LAMICTAL 100 mgRomania · 100mg · compr. · Glaxosmithkline (Ireland) LimitedSame substance
- LAMICTAL 100mgRomania · 100mg · compr. · The Wellcome Foundation LTDSame substance
- LAMICTAL 2 mgRomania · 2mg · compr. mast./disp. · Glaxosmithkline (Ireland) LimitedSame substance
- Lamofree ER Tablets 100mgTaiwan · 持續性釋放錠 · 美時化學製藥股份有限公司Same substance
- Lamofree ER Tablets 25mgTaiwan · 持續性釋放錠 · 美時化學製藥股份有限公司Same substance
- Lamofree ER Tablets 50mgTaiwan · 持續性釋放錠 · 美時化學製藥股份有限公司Same substance
Packs
| Pack | Code | Status |
|---|---|---|
| CRISOMET 25 mg COMPRIMIDOS MASTICABLES/DISPERSABLES, 56 comprimidos | 731563 | |
| CRISOMET 25 mg COMPRIMIDOS MASTICABLES/DISPERSABLES , 56 comprimidos | 917310 |
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Agencia Española de Medicamentos y Productos Sanitarios
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Lamotrigine
- Strength
- 25 mg
- Dosage form
- comprimido masticable y dispersable
- Route
- vía oral
- Register
- Spain (AEMPS)
- Status
- Marketed
- Status in the register
- Autorizado, comercializado
- Authorised
- 18 Mar 2001
- Registration
- 63747
- Marketing authorisation holder
- Glaxosmithkline S.A.
- Procedure
- National, MRP or DCP
- Supply
- Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración